Japan Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032

Japan Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A18702
Buy Now

1   Preface 
2   Scope and Methodology 

    2.1    Objectives of the Study 
    2.2    Stakeholders 
    2.3    Data Sources 
        2.3.1    Primary Sources 
        2.3.2    Secondary Sources 
    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach 
        2.4.2    Top-Down Approach 
    2.5    Forecasting Methodology 
3   Executive Summary 
4   Japan Cancer Biomarkers Market - Introduction 

    4.1    Overview 
    4.2    Market Dynamics 
    4.3    Industry Trends 
    4.4    Competitive Intelligence 
5   Japan Cancer Biomarkers Market Landscape 
    5.1    Historical and Current Market Trends (2018-2023) 
    5.2    Market Forecast (2024-2032) 
6   Japan Cancer Biomarkers Market - Breakup by Profiling Technology
    6.1    Omic Technologies
        6.1.1 Overview 
        6.1.2 Historical and Current Market Trends (2018-2023) 
        6.1.3 Market Forecast (2024-2032) 
    6.2    Imaging Technologies
        6.2.1 Overview 
        6.2.2 Historical and Current Market Trends (2018-2023) 
        6.2.3 Market Forecast (2024-2032) 
    6.3    Immunoassays
        6.3.1 Overview 
        6.3.2 Historical and Current Market Trends (2018-2023) 
        6.3.3 Market Forecast (2024-2032) 
    6.4    Cytogenetics
        6.4.1 Overview 
        6.4.2 Historical and Current Market Trends (2018-2023) 
        6.4.3 Market Forecast (2024-2032) 
7   Japan Cancer Biomarkers Market - Breakup by Biomolecule
    7.1    Genetic Biomarkers
        7.1.1 Overview 
        7.1.2 Historical and Current Market Trends (2018-2023) 
        7.1.3 Market Forecast (2024-2032) 
    7.2    Protein Biomarkers
        7.2.1 Overview 
        7.2.2 Historical and Current Market Trends (2018-2023) 
        7.2.3 Market Forecast (2024-2032) 
    7.3    Glyco-Biomarkers
        7.3.1 Overview 
        7.3.2 Historical and Current Market Trends (2018-2023) 
        7.3.3 Market Forecast (2024-2032) 
8   Japan Cancer Biomarkers Market - Breakup by Cancer Type
    8.1    Breast Cancer
        8.1.1 Overview 
        8.1.2 Historical and Current Market Trends (2018-2023) 
        8.1.3 Market Forecast (2024-2032) 
    8.2    Lung Cancer
        8.2.1 Overview 
        8.2.2 Historical and Current Market Trends (2018-2023) 
        8.2.3 Market Forecast (2024-2032) 
    8.3    Colorectal Cancer
        8.3.1 Overview 
        8.3.2 Historical and Current Market Trends (2018-2023) 
        8.3.3 Market Forecast (2024-2032) 
    8.4    Prostate Cancer
        8.4.1 Overview 
        8.4.2 Historical and Current Market Trends (2018-2023) 
        8.4.3 Market Forecast (2024-2032) 
    8.5    Stomach Cancer
        8.5.1 Overview 
        8.5.2 Historical and Current Market Trends (2018-2023) 
        8.5.3 Market Forecast (2024-2032) 
    8.6    Others
        8.6.1 Historical and Current Market Trends (2018-2023) 
        8.6.2 Market Forecast (2024-2032) 
9   Japan Cancer Biomarkers Market - Breakup by Application
    9.1    Diagnostics
        9.1.1 Overview 
        9.1.2 Historical and Current Market Trends (2018-2023) 
        9.1.3 Market Forecast (2024-2032) 
    9.2    Prognostics
        9.2.1 Overview 
        9.2.2 Historical and Current Market Trends (2018-2023) 
        9.2.3 Market Forecast (2024-2032) 
    9.3    Risk Assessment
        9.3.1 Overview 
        9.3.2 Historical and Current Market Trends (2018-2023) 
        9.3.3 Market Forecast (2024-2032) 
    9.4    Drug Discovery and Development
        9.4.1 Overview 
        9.4.2 Historical and Current Market Trends (2018-2023) 
        9.4.3 Market Forecast (2024-2032) 
    9.5    Others
        9.5.1 Historical and Current Market Trends (2018-2023) 
        9.5.2 Market Forecast (2024-2032) 
10   Japan Cancer Biomarkers Market - Breakup by End User
    10.1    Hospitals
        10.1.1 Overview 
        10.1.2 Historical and Current Market Trends (2018-2023) 
        10.1.3 Market Forecast (2024-2032) 
    10.2    Academic and Research Institutions
        10.2.1 Overview 
        10.2.2 Historical and Current Market Trends (2018-2023) 
        10.2.3 Market Forecast (2024-2032)  
    10.3    Ambulatory Surgical Centers
        10.3.1 Overview 
        10.3.2 Historical and Current Market Trends (2018-2023) 
        10.3.3 Market Forecast (2024-2032) 
    10.4    Diagnostic Laboratories
        10.4.1 Overview 
        10.4.2 Historical and Current Market Trends (2018-2023) 
        10.4.3 Market Forecast (2024-2032) 
    10.5    Others
        10.5.1 Historical and Current Market Trends (2018-2023) 
        10.5.2 Market Forecast (2024-2032) 
11   Japan Cancer Biomarkers Market – Breakup by Region
    11.1    Kanto Region
        11.1.1 Overview 
        11.1.2 Historical and Current Market Trends (2018-2023) 
        11.1.3 Market Breakup by Profiling Technology 
        11.1.4 Market Breakup by Biomolecule 
        11.1.5 Market Breakup by Cancer Type
        11.1.6 Market Breakup by Service
        11.1.7 Market Breakup by End User 
        11.1.8 Key Players 
        11.1.9 Market Forecast (2024-2032) 
    11.2    Kansai/Kinki Region
        11.2.1 Overview 
        11.2.2 Historical and Current Market Trends (2018-2023) 
        11.2.3 Market Breakup by Profiling Technology 
        11.2.4 Market Breakup by Biomolecule 
        11.2.5 Market Breakup by Cancer Type
        11.2.6 Market Breakup by Service
        11.2.7 Market Breakup by End User 
        11.2.8 Key Players 
        11.2.9 Market Forecast (2024-2032) 
    11.3    Central/ Chubu Region
        11.3.1 Overview 
        11.3.2 Historical and Current Market Trends (2018-2023) 
        11.3.3 Market Breakup by Profiling Technology 
        11.3.4 Market Breakup by Biomolecule 
        11.3.5 Market Breakup by Cancer Type
        11.3.6 Market Breakup by Service
        11.3.7 Market Breakup by End User 
        11.3.8 Key Players 
        11.3.9 Market Forecast (2024-2032) 
    11.4    Kyushu-Okinawa Region 
        11.4.1 Overview 
        11.4.2 Historical and Current Market Trends (2018-2023) 
        11.4.3 Market Breakup by Profiling Technology 
        11.4.4 Market Breakup by Biomolecule 
        11.4.5 Market Breakup by Cancer Type
        11.4.6 Market Breakup by Service
        11.4.7 Market Breakup by End User 
        11.4.8 Key Players 
        11.4.9 Market Forecast (2024-2032)
    11.5    Tohoku Region
        11.5.1 Overview 
        11.5.2 Historical and Current Market Trends (2018-2023) 
        11.5.3 Market Breakup by Profiling Technology 
        11.5.4 Market Breakup by Biomolecule 
        11.5.5 Market Breakup by Cancer Type
        11.5.6 Market Breakup by Service
        11.5.7 Market Breakup by End User 
        11.5.8 Key Players 
        11.5.9 Market Forecast (2024-2032)  
    11.6    Chugoku Region
        11.6.1 Overview 
        11.6.2 Historical and Current Market Trends (2018-2023) 
        11.6.3 Market Breakup by Profiling Technology 
        11.6.4 Market Breakup by Biomolecule 
        11.6.5 Market Breakup by Cancer Type
        11.6.6 Market Breakup by Service
        11.6.7 Market Breakup by End User 
        11.6.8 Key Players 
        11.6.9 Market Forecast (2024-2032)
    11.7    Hokkaido Region
        11.7.1 Overview 
        11.7.2 Historical and Current Market Trends (2018-2023) 
        11.7.3 Market Breakup by Profiling Technology 
        11.7.4 Market Breakup by Biomolecule 
        11.7.5 Market Breakup by Cancer Type
        11.7.6 Market Breakup by Service
        11.7.7 Market Breakup by End User 
        11.7.8 Key Players 
        11.7.9 Market Forecast (2024-2032) 
    11.8    Shikoku Region
        11.8.1 Overview 
        11.8.2 Historical and Current Market Trends (2018-2023) 
        11.8.3 Market Breakup by Profiling Technology 
        11.8.4 Market Breakup by Biomolecule 
        11.8.5 Market Breakup by Cancer Type
        11.8.6 Market Breakup by Service
        11.8.7 Market Breakup by End User 
        11.8.8 Key Players 
        11.8.9 Market Forecast (2024-2032)  
12   Japan Cancer Biomarkers Market – Competitive Landscape 
    12.1    Overview 
    12.2    Market Structure 
    12.3    Market Player Positioning 
    12.4    Top Winning Strategies 
    12.5    Competitive Dashboard 
    12.6    Company Evaluation Quadrant 
13   Profiles of Key Players 
    13.1    Company A  
        13.1.1 Business Overview 
        13.1.2 Product Portfolio 
        13.1.3 Business Strategies 
        13.1.4 SWOT Analysis 
        13.1.5 Major News and Events 
    13.2    Company B 
        13.2.1 Business Overview 
        13.2.2 Product Portfolio 
        13.2.3 Business Strategies 
        13.2.4 SWOT Analysis 
        13.2.5 Major News and Events 
    13.3    Company C 
        13.3.1 Business Overview 
        13.3.2 Product Portfolio 
        13.3.3 Business Strategies 
        13.3.4 SWOT Analysis 
        13.3.5 Major News and Events 
    13.4    Company D  
        13.4.1 Business Overview 
        13.4.2 Product Portfolio 
        13.4.3 Business Strategies 
        13.4.4 SWOT Analysis 
        13.4.5 Major News and Events 
    13.5    Company E 
        13.5.1 Business Overview 
        13.5.2 Product Portfolio 
        13.5.3 Business Strategies 
        13.5.4 SWOT Analysis 
        13.5.5 Major News and Events     
 
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report. 
 
14   Japan Cancer Biomarkers Market - Industry Analysis 

    14.1    Drivers, Restraints, and Opportunities 
        14.1.1 Overview 
        14.1.2 Drivers 
        14.1.3 Restraints 
        14.1.4 Opportunities 
    14.2   Porters Five Forces Analysis 
        14.2.1 Overview 
        14.2.2 Bargaining Power of Buyers 
        14.2.3 Bargaining Power of Suppliers 
        14.2.4 Degree of Competition 
        14.2.5 Threat of New Entrants 
        14.2.6 Threat of Substitutes 
    14.3    Value Chain Analysis 
15   Appendix

Japan Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More